Hormone replacement therapy. Risks, benefits, and costs
- PMID: 8219862
- PMCID: PMC2379850
Hormone replacement therapy. Risks, benefits, and costs
Abstract
Epidemiologic evidence on the risks and benefits of hormone replacement therapy (HRT) for postmenopausal women is accumulating. The apparent 50% reduction in risk of cardiovascular mortality could lead to universal HRT. Until a prospective, controlled trial is concluded, women must consider all the consequences of HRT. For the undecided, who would take HRT only to prevent osteoporosis, bone mass estimates might be warranted.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources